Immunotherapy in Lung Cancer: Current Landscape and Future DirectionsHirva Mamdani, Shadia I. Jalal, Sandro Matosevic et al.|Frontiers in Immunology|2022Cited by 373
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinomaAhmed Bilal Khalid, Shadia I. Jalal, Christos Fountzilas et al.|Frontiers in Oncology|2024Cited by 4